Perth, Australia (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of the management presentation published by MediPharm Labs Inc ("MediPharm Labs") (TSX-V: LABS).
The presentation is also available to view and download at:
ir.medipharmlabs.com/company-information
MMJ owns 5.88 million shares and 2.94 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the presentation, please visit:
http://abnnewswire.net/lnk/8VP95T0H
The presentation is also available to view and download at:
ir.medipharmlabs.com/company-information
MMJ owns 5.88 million shares and 2.94 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.
To view the presentation, please visit:
http://abnnewswire.net/lnk/8VP95T0H
About MMJ PhytoTech Ltd:
MMJ PhytoTech Limited (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/
Source:
MMJ PhytoTech Ltd
Contact:
Investor and Media Enquiries: Jason Conroy Chief Executive Officer T: +61-2-8098-0819 E: info@mmjphytotech.com.au